Recent advances in nanotechnology have made significant progress in biomedical
sciences. However, there are growing concerns that exposure to naturally-occurring and …

Many lung diseases result in fibrotic remodelling. Fibrotic lung disorders can be divided into
diseases with known and unknown aetiology. Among those with unknown aetiology …

Rationale: The serial computed tomography findings and prognosis of the acute
exacerbation of idiopathic pulmonary fibrosis (IPF) are not yet well defined in a larger …

Activated factor Xa (FXa) is traditionally known as an important player in the coagulation
cascade responsible for thrombin generation. Long considered a passive bystander, it is …

Idiopathic pulmonary fibrosis (IPF) therapy has always been a big and long-standing
challenge in clinical practice due to the lack of miraculous medicine. Mesenchymal stem …

Idiopathic pulmonary fibrosis (IPF), ie, usual interstitial pneumonia in histopathology, is a
disease characterized by tissue destruction and active areas of fibroproliferation in the lung …

Fibrosis is characterized by excessive accumulation of extracellular matrix (ECM) in
basement membranes and interstitial tissues, resulting from increased synthesis or …

Pulmonary fibrosis (PF) is characterized by inflammation and fibrosis of the interstitium and
destruction of alveolar histoarchitecture ultimately leading to a fatal impairment of lung …

Idiopathic pulmonary fibrosis (IPF) and bleomycin-induced pulmonary fibrosis are
associated with surfactant system dysfunction, alveolar collapse (derecruitment), and …

Pulmonary fibrosis is a group of disorders characterized by accumulation of scar tissue in
the lung interstitium, resulting in loss of alveolar function, destruction of normal lung …